LINEZOLID ML linezolid 600 mg tablet bottle

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

linezolid, Quantity: 600 mg

Disponible depuis:

Amneal Pharma Australia Pty Ltd

DCI (Dénomination commune internationale):

Linezolid

forme pharmaceutique:

Tablet

Composition:

Excipient Ingredients: povidone; croscarmellose sodium; purified talc; silicon dioxide; microcrystalline cellulose; diethyl phthalate; magnesium stearate; ethylcellulose; hypromellose; titanium dioxide

Mode d'administration:

Oral

Unités en paquet:

10, 30

Type d'ordonnance:

(S4) Prescription Only Medicine

indications thérapeutiques:

Linezolid is indicated for the treatment of suspected or proven infections due to Gram positive organisms resistant to multiple classes of antibiotics, including methicillin resistant Staphylococcus species and vancomycin resistant Enterococcus species.,Linezolid is active against Gram-positive bacteria only. It has no clinical activity against Gram-negative pathogens. Specific Gram-negative therapy is required if a concomitant Gram- negative pathogen is documented or suspected.

Descriptif du produit:

Visual Identification: White to off white, oval shaped, film coated tablets, debossed with AI006 on one side and plain on the other side.; Container Type: Bottle; Container Material: HDPE; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Statut de autorisation:

Licence status A

Date de l'autorisation:

2016-06-01